Brief: Aptahem: New Sepsis Data Shows Good Effect In Apta-1 Treated Primates
Nov 14 (Reuters) - Aptahem AB APTA.TE :
* NEW SEPSIS DATA SHOWS GOOD EFFECT IN APTA-1 TREATED PRIMATES
* FOCUS IS TO START CLINICAL TRIAL WITH APTA-1
Source text for Eikon: ID:nWkr6Cfh0f
Further company coverage: APTA.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman